A recent study conducted by consumer advocacy group Which? has uncovered significant discrepancies in the omega-3 supplement market, where products boasting “high strength” claims often contain unexpectedly low levels of the key active ingredients, EPA and DHA. This revelation raises concerns for health-conscious consumers who may be paying a premium for subpar nutritional value.
The Study’s Findings
Which? nutrition experts meticulously analysed 24 omega-3 supplements against the guidelines set forth by the Scientific Advisory Committee on Nutrition (SACN), which recommends an average daily intake of 450mg of combined EPA and DHA. The benchmark for products marketed as “high strength” was established at 1,000mg, based on scientific evidence highlighting health benefits at this level for specific demographics.
Shockingly, the investigation found that numerous products marketed under the high strength banner contained significantly less of these essential fatty acids than the recommended daily amount. For instance, the omega-3 supplements from Superdrug, Morrisons, and Sainsbury’s each delivered only 250mg of EPA and DHA combined, despite their claims. This discrepancy means that consumers might be paying double the price for products that offer no more active omega-3 than their more economical counterparts.
Price vs. Nutritional Value
The research highlighted stark contrasts in pricing and nutritional content. For example, Sainsbury’s high strength offering, containing merely 250mg of EPA and DHA, is priced at 14p per dose—twice the cost of nutritionally equivalent options available at Asda and Tesco, which retail for 7p per dose. Additionally, Holland & Barrett’s product, labelled as high strength, costs 27p per dose despite providing just 375mg of EPA and DHA, a mere 75mg increase over its standard variant priced at 22p.
On the flip side, brands such as Nutravita, Weightworld, and Zipvit were found to offer products for less than 20p per dose while delivering at least 1,000mg of EPA and DHA. This stark contrast sheds light on the potential for consumers to be misled by prominent packaging claims that focus on total fish oil content rather than the more critical active ingredient concentrations.
Clarity in Labelling
Which? stressed the importance of scrutinising the back label, where the EPA and DHA content is often printed in smaller text, overshadowed by larger, more eye-catching claims about total fish oil. Nutritionist Shefalee Loth commented, “Our research shows that cheaper alternatives can often provide just as much—if not more—nutritional value while offering far better value for money.”
The retailers in question defended their labelling practices, asserting compliance with existing regulations. A spokesperson from Superdrug indicated that their high strength classification is valid as the product contains 250mg of EPA and DHA, exceeding the 80mg threshold required by Regulation (EC) No. 1924/2006. Similarly, representatives from Sainsbury’s and Morrisons confirmed that their products meet regulatory standards for omega-3 claims. Holland & Barrett explained that there is no universally accepted definition of “high strength,” and they use the term to help customers navigate their diverse product range.
Why it Matters
This investigation highlights a significant gap in consumer awareness regarding nutritional supplements. As health trends continue to rise, the potential for misinformation and misleading labelling poses a serious risk to consumers seeking to enhance their well-being through dietary supplements. The findings urge shoppers to be vigilant, advocating for transparency in the industry to ensure that they receive genuine value for their money. In an era where health is paramount, ensuring that consumers can make informed choices about their supplements is not just beneficial—it is essential.
